Skip to main content
logo
Coloplast A/S (CLPBY)
OTCMKTS · Delayed Price · Currency is USD
6.69
-0.05 (-0.74%)
At close: Mar 27, 2026

Revenue

Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13
Ostomy Care Revenue
9.90B9.55B
Ostomy Care Revenue Growth
3.69%5.77%
Continence Care Revenue
8.98B8.54B
Continence Care Revenue Growth
5.20%7.31%
Chronic Care Revenue
18.88B18.09B
Chronic Care Revenue Growth
4.40%6.49%
Voice and Respiratory Care Revenue
2.28B2.11B
Voice and Respiratory Care Revenue Growth
8.06%8.82%
Interventional Urology Revenue
2.78B2.78B
Interventional Urology Revenue Growth
0.32%3.78%
Advanced Wound Dressings Revenue
2.68B3.03B
Advanced Wound Dressings Revenue Growth
-11.83%7.21%
Biologics Revenue
1.25B1.03B
Biologics Revenue Growth
22.22%1268.00%
Advanced Wound Care Revenue
3.93B4.06B
Advanced Wound Care Revenue Growth
-3.23%39.76%
Revenue (Total)
27.87B27.03B
Revenue (Total) Growth
3.12%10.33%

Revenue by Geography

Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13
European Markets Revenue
15.51B14.75B
European Markets Revenue Growth
5.15%6.05%
Other Developed Markets Revenue
7.83B7.75B
Other Developed Markets Revenue Growth
1.06%19.54%
Emerging Markets Revenue
4.54B4.53B
Emerging Markets Revenue Growth
0.04%10.26%
Revenue (Total)
27.87B27.03B
Revenue (Total) Growth
3.12%10.33%

EBIT

Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13
Chronic Care Segment EBIT
11.06B10.44B
Chronic Care Segment EBIT Growth
5.96%6.44%
Voice and Respiratory Care Segment EBIT
837.00M736.00M
Voice and Respiratory Care Segment EBIT Growth
13.72%10.51%
Interventional Urology Segment EBIT
984.00M976.00M
Interventional Urology Segment EBIT Growth
0.82%3.06%
Advanced Wound Dressings Segment EBIT
1.11B1.15B
Advanced Wound Dressings Segment EBIT Growth
-4.16%7.86%
Biologics Segment EBIT
159.00M101.00M
Biologics Segment EBIT Growth
57.43%1022.22%
Advanced Wound Care Segment EBIT
1.26B1.25B
Advanced Wound Care Segment EBIT Growth
0.80%16.33%
Operating Income (Total)
7.20B7.32B
Operating Income (Total) Growth
-1.63%8.11%

Key Performance Indicators

Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13
Ostomy Care Organic Growth
6.00%7.00%
Continence Care Organic Growth
8.00%8.00%
Voice and Respiratory Care Organic Growth
9.00%11.00%
Advanced Wound Care Organic Growth
8.00%10.00%
Interventional Urology Organic Growth
2.00%5.00%
Total Organic Growth
7.00%8.00%
Updated Sep 30, 2025. Data Source: Fiscal.ai.